6.6.1. Calcitonin and parathyroid hormone

Restrictions:
Restricted to specialist use for the treatment of severe osteoporosis in women with at least two prior vertebral fractures or equivalent high risk according to local prescribing protocol. The use for the treatment of osteoporosis in men is unlicensed and therefore non-Formulary.
Prescribing Notes:
Parathyroid hormone injection (Natpar®) for chronic hypoparathyrodism is not recommended for use by SMC and is non-Formulary

Restrictions:
Restricted to specialist use for the treatment of established severe osteoporosis in post-menopausal women for whom parathyroid hormone (PTH 1-84) is not tolerated or appropriate. The treatment of osteoporosis associated with glucocorticoid therapy and the treatment of osteoporosis in men at increased risk of fracture is not recommended by SMC and is non-Formulary.
Prescribing Notes:
The preferred brand is Movymia®.